Technology Partnership Between InterComponentWare AG (ICW) and Roche Diabetes Care Results in Launch of Overarching Web-based Solution

InterComponentWareICW technology sits in the center of the new online portal Accu-Chek® Connect which was recently introduced by Roche Diabetes Care. This new web-based solution empowers healthcare professionals and people living with diabetes to ease daily diabetes management. It enables seamless collaboration based on a central information view across blood glucose measurement devices, smartphone-apps, and offline solutions in current use.

ICW provided technology and development expertise into the technology partnership with Roche Diabetes Care, a global leader in diabetes management solutions. Jointly a next-generation system for effective and efficient self-management of individual diabetes therapies by people with diabetes was created, which allows to easily involve their healthcare professionals and caregivers into the process. The solution is built on top of a technology platform that facilitates the secure management of data as well as the shared use of that data between healthcare professionals and people with diabetes via the web. The solution also provides substantial reporting, intuitive graphics and easy-to-interpret visualization of relevant blood glucose and insulin data.

Regular and structured capture and evaluation of blood glucose and insulin data plays a pivotal part in effective diabetes management, but is usually challenging since multiple devices and data management approaches are used. Being able to consolidate all data in Roche Diabetes Care's shared Accu-Chek Connect platform ensures having the most reliable information base for their diabetes self-management to the person with diabetes. They can also use a simple and straightforward way of granting their healthcare professional access to all data relevant for making therapy decisions. This may result in greater adherence to recommendations and goals, and can lead to a better managed diabetes condition.

The online portal was built on top of the ICW eHealth Framework, which provides a modular, standards-oriented, and mature foundation for integration and secure management of sensitive personal health information. The ICW eHealth Framework enabled transferring measurement, medical and other diabetes related data from blood glucose measurement devices via PCs or smartphones to the web-based solution. Overlapping data streams are aggregated into a unique record, from which information required by the diabetes specialist or general practitioner for successful therapeutic intervention is derived. Managing this wealth of information on top of a framework that was built with personal health information security as an underlying design principle simplified adhering to different data privacy regulations across multiple target countries and provided corresponding auditability.

In partnership with Roche Diabetes Care, ICW configured and custom developed the aspects related to diabetes management and visualization. Scott Baxter, Head of Diabetes Management & Platform Solutions at Roche Diagnostics: "ICW's experience in state-of-the-art application design, information security and agile development significantly helped achieve the key goal of an intuitive and easy-to-use solution."

Related news articles:

About InterComponentWare AG
ICW is an international software company in the healthcare market, based in Walldorf, Germany. Our products and solutions support multiple stakeholders and integrate heterogeneous systems (connect), improve the efficiency of managing a patient through the care continuum (manage) and facilitate the engagement of patients in the treatment process (personalize). Our products are based on the latest technologies and standards, and support rapid development of eHealth solutions and flexible implementation of integrated care projects. Together with our partners, we deliver safe and sustainable eHealth solutions for more than 20 million patients and 10,000 providers.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...